Mesenchymal stem cell infusion as a promising therapeutic approach to treat coronavirus disease 2019 patients

Mesenchymal stem cell infusion as a promising therapeutic approach to treat coronavirus disease 2019 patients

Coronavirus disease 2019 (COVID-19) is a highly contagious respiratory infection that emerges as a serious healthcare problem and becomes a global pandemic. The disease is caused by a novel virus called SARS-CoV-2. The initial site of infection is the pulmonary epithelial cells when the surface spik...

Full description

Bibliographic Details
Main Author: Nihal AlMuraikhi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Nature and Science of Medicine
Subjects:
angiotensin i-converting enzyme 2 receptor
anti-inflammation
coronavirus disease 2019
cytokine storm
immunomodulation
mesenchymal stem cells
regeneration
Online Access:http://www.jnsmonline.org/article.asp?issn=2589-627X;year=2020;volume=3;issue=4;spage=322;epage=328;aulast=AlMuraikhi

Internet

http://www.jnsmonline.org/article.asp?issn=2589-627X;year=2020;volume=3;issue=4;spage=322;epage=328;aulast=AlMuraikhi

Similar Items